The Third International Workshop on Multiple Endocrine Neoplasia Type 2 Syndromes by Raue, Friedhelm & Jackson, Charles E.
Henry Ford Hospital Medical Journal 
Volume 37 Number 3 Article 2 
9-1989 
The Third International Workshop on Multiple Endocrine 
Neoplasia Type 2 Syndromes 
Friedhelm Raue 
Charles E. Jackson 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Raue, Friedhelm and Jackson, Charles E. (1989) "The Third International Workshop on Multiple Endocrine 
Neoplasia Type 2 Syndromes," Henry Ford Hospital Medical Journal : Vol. 37 : No. 3 , 98. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol37/iss3/2 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
The Third International Workshop on Multiple Endocrine Neoplasia 
lype 2 Syndromes 
Science is the most communal of human endeavors 
Lewis Thomas 
(Foreign Affairs 1984;63:966-94) 
T he Third International Workshop on Multiple Endocrine Neoplasia Type 2 (MEN 2) was held in Heidelberg, West 
Germany, September 28-30, 1989. The first workshop, held in 
Kingston, Ontario, in 1984, had over 40 parficipants from eight 
countries (1), and the second workshop, hetd in Cambridge, 
England, September 17-20, 1986, attracted over 75 participants 
from 14 countries (2). The friendly, wide-ranging discussions al-
lowed an exchange of ideas which has provided a stimulus to 
research in this field and to the intemational collaboration which 
has contributed significantly to the progress not onty in under-
standing this rare hereditary malignant disease but atso in our 
understanding of carcinogenesis in general. This third work-
shop, with over 92 participants from 18 countries, was charac-
terized by the same friendly collegiality and international 
cooperation.* 
At the time of the second workshop in Cambridge in 1986, the 
gene for MEN 2 had not yet been localized. Largely due to col-
laboration arranged through these workshops, the localization 
of the gene to chromosome 10 was reported the following year 
by two groups composed of many of the participants of these 
workshops (3,4). Because of these major advances, it seemed 
appropriate to begin this issue with the article by Simpson and 
Kidd entitled "Closing in on the MEN2A Locus" (pp 100-105) 
followed by other genetic papers directed toward further lo-
calizafion of the gene(s) and the applications of these findings in 
clinical situations and in understanding the mechanisms of tu-
mor initiation and progression (pp 106-119). Although some par-
ticipants had obtigated their materiat to other joumals, the man-
uscripts published here provide examples of the family 
screening and clinical studies (pp 120-166), imaging technique 
studies (pp 167-184), and pathology and cell biology studies (pp 
185-203) being perfonned on MEN 2 throughout the worid. Al-
though abstracts of some of the additional material presented are 
published here (pp 204-209), other important papers and formal 
and informal discussions are not covered (for example, the re-
port by N. T. Schulz and others from the US National Cancer 
Institute on the development of medullary thyroid cancers and 
pheochromocytomas in transgenic mice carrying the c-mos 
proto-oncogene [data to be published elsewhere in 1990]). The 
rapid progress in many aspects of MEN 2 provides exciting 
prospects for the next workshop to be held in Houston, Texas, in 
1991.t 
Financiat contributions from the following organizations for 
the third workshop have been greatly appreciated: Deutsche For-
schungsgemeinschaft, Bonn, West Germany; Deutsche 
Gesetlschaft fur Endokrinologie; Tumorzentmm Heidelberg, 
Mannheim, West Germany; Dykstra Foundation, Detroit, MI; 
Firma Henning Berlin GmbH, Berlin, West Germany; Firma 
Rorer, Bielefeld, West Germany; Firma Isotopen Diagnostik 
CIS, Dreieich. West Germany; Firma Amersham Buehler, 
Braunschweig, West Germany; and Firma IBL, Hamburg, West 
Germany. 
Friedhelm Raue, MDt 
Charles E. Jackson, MD§ 
Guest Coeditors 
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'^ Heidelberg provided a beautiful setting for the work.shop and the participants were im-
pressed with the efficient organization and warm hospitality of Friedhelm Raue, Reinhard 
Ziegler. and their committees (CEJ). 
tArrangements are being made for the Fourth Intemational Work.shop on MEN 2 to be 
held in Houston, Texas, in September or October 1991. For further information contact Dr 
Robert P. Gagel, Laboratory of MolecularandCelluIarEndocrinology (IIIE), Veterans Af-
fairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030. 
^Department of internal Medicine, Endocrinology & Metabolism. University of 
Heidelberg, West Germany. 
§Department of Intemal Medicine, Division of Clinical & Molecular Genetics, Henry 
Ford Hospital. 
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